Background

Dengue is a viral disease transmitted mainly by Aedes mosquitoes, with four described serotypes and wide circulation in tropical and subtropical regions.

The infection can range from mild, nonspecific febrile illness to severe forms, especially in secondary infections or in patients with risk factors. Therefore, diagnosis at the right time is essential.

Chemiluminescence tests for IgM and IgG antibodies are a suitable serological solution for dengue, due to their sensitivity, automation, and ability to integrate into routine sample processing.

Dengue VirClia

Product features

Chemiluminescent immunoassays (CLIA) to test antibodies against dengue virus in human serum or plasma samples.

  • Monotest format with ready-to-use reagents.
  • Highly specific IgM immunocapture method.
  • Simple and automated protocol, with fast results.
  • Customizable configuration of samples and reagents according to laboratory needs.
  • Each monotest includes a calibrator and a negative control, enabling individual validation and interpretation of each sample.
  • Use of primary tubes, with no need for manual pipetting.
virclia monotest

PRODUCTS

DENGUE VIRCLIA® IgG MONOTEST

CE
Indirect chemiluminescent immunoassay (CLIA) to test IgG antibodies against dengue virus in human serum/plasma.

Analytes: Dengue

Reference VCM023
Pack size 24 test

DENGUE VIRCLIA® IgM MONOTEST

CE
Capture chemiluminescent immunoassay (CLIA) to test IgM antibodies against dengue virus in human serum/plasma.

Analytes: Dengue

Reference VCM024
Pack size 24 test

USED ON

VIRCLIA® LOTUS

virclia_lotus.jpeg

A compact automated CLIA platform for VirClia® infectious disease testing, combining ready-to-use single-test flexibility with continuous random access efficiency.

MORE RESOURCES

Virus/Bacterias
RELATED VIRUSES/BACTERIA

Related germs and organisms categorized for this product line.

Flyers
FLYERS

Downloadable PDF materials, brochures, and technical documents.

Blog
BLOG

The latest insights, news, and research articles from our scientific team.

Infecciones vaginales polimicrobianas: por qué importan los controles de terceros en diagnóstico molecular
02 July 2026

Infecciones vaginales polimicrobianas: por qué importan los controles de terceros en diagnóstico molecular

Understanding the complexity of vaginal infectionsVaginal infections are among the most frequent reasons for gynecological consultation, but their dia...

Beyond detection: H. pylori testing in today’s laboratory workflow
26 June 2026

Beyond detection: H. pylori testing in today’s laboratory workflow

Helicobacter pylori remains a highly relevant target in gastrointestinal diagnostics. It is a familiar pathogen, but its clinical importance has not d...

Aspergillus galactomannan: a practical biomarker for invasive aspergillosis diagnosis
15 May 2026

Aspergillus galactomannan: a practical biomarker for invasive aspergillosis diagnosis

Invasive aspergillosis is still one of the most difficult fungal infections to diagnose early. It mainly affects patients with weakened immune systems...

Bibliography
BIBLIOGRAPHY

Scientific bibliography and references related to this product.

Guigon A, Coulon P, Pezzi L, Regueme A, Debuysschere C, Lazrek M, et al. Evaluation of a Fully Automated Assay for Detection of Antidengue IgM Antibodies in a Nonendemic Area. Journal of Tropical Medicine. 2025 Jan;2025(1).